A Ducolone - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Bulletin Du Cancer|January 1, 1991

[Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study]E Quoix, A Dietemann, J Charbonneau, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)R Gervais, A Ducolone, J-L Breton, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003

Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Bulletin Du Cancer|January 1, 1991

[Is chemotherapy with cisplatin useful in non small cell bronchial cancer at staging IV? Results of a randomized study]E Quoix, A Dietemann, J Charbonneau, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)R Gervais, A Ducolone, J-L Breton, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003

Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancerE Quoix, B Lebeau, A Depierre, et al.

Pageof 2